Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper

X. Bossuyt*, J. Damoiseaux, N. Rasmussen, P. van Paassen, B. Hellmich, B. Baslund, D. Blockmans, P. Vermeersch, M. Lopez-Hoyos, M. Vercammen, E. Barret, F. Hammar, U. Leinfelder, M. Mahler, N. Olschowka, D. Roggenbuck, W. Schlumberger, R. Walker, J. Ronnelid, J.W.C. TervaertE. Csernok, W. Fierz, European Federation of Laboratory Medicine (EFLM) Task and Finish Group “Autoimmunity Testing”, European Autoimmune Standardization Initiative (EASI), European Consensus Finding Study Group on autoantibodies (ECFSG)

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

14 Citations (Web of Science)
85 Downloads (Pure)
Original languageEnglish
Pages (from-to)E35-E39
Number of pages5
JournalClinical Chemistry and Laboratory Medicine
Issue number2
Publication statusPublished - 1 Feb 2021


  • antineutrophil cytoplasmic antibodies (anca)
  • harmonization
  • sars-cov-2 antibody
  • vasculitis
  • SARS-CoV-2 antibody
  • antineutrophil cytoplasmic antibodies (ANCA)

Cite this